Dear Readers: We normally publish this newsletter every two weeks, but because of a two-week pause in FDA Safety Labeling Change posting activity, followed by a release of the backlogged updates, we are "catching up" by sending this extra edition with summaries of four notable safety-related disclosures.
Share this post
February 2025 Drug Safety Part 2: FDA REMS…
Share this post
Dear Readers: We normally publish this newsletter every two weeks, but because of a two-week pause in FDA Safety Labeling Change posting activity, followed by a release of the backlogged updates, we are "catching up" by sending this extra edition with summaries of four notable safety-related disclosures.